3-phenyllactic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
3-phenyllactic acid: alpha-hydroxy analog of phenylalanine; RN given refers to cpd without isomeric designation
3-phenyllactic acid : A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lunavath, R | 1 |
| Mohammad, SH | 1 |
| Bhukya, KK | 1 |
| Barigela, A | 1 |
| Banoth, C | 1 |
| Banothu, AK | 1 |
| Bhukya, B | 1 |
1 other study available for 3-phenyllactic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated mucormycosis causing fungi.
Topics: Animals; Anti-Infective Agents; Bees; COVID-19; Fungi; Humans; Lactobacillales; Mucormycosis; Polyes | 2023 |